After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Nuvation Bio Inc (NUVB) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.01, or -0.86%, to $1.15. The Nuvation Bio Inc has recorded 145,017 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update.
Stocks Info
As a NYSE listed company, NUVB falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $1.16 and fluctuated between $1.1900 as its day high and $0.9500 as its day low. The current market capitalization of Nuvation Bio Inc is $255.13M. A total of 10.57 million shares were traded on the day, compared to an average of 935.02K shares.
Insider Activity
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, NUVB has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 7 BUYs and 0 SELLs from insiders. Insiders purchased 5,563,100 shares during that period but sold 0.
In the most recent transaction, NODELMAN OLEG bought 53,000 shares of NUVB for 1.36 per share on Feb 21. After the transaction, the Director now owns 12,674,775 company shares. In a previous transaction on Feb 20, NODELMAN OLEG bought 117,100 shares at 1.36 per share. NUVB shares that Director owns now total 12,621,775.
Among the insiders who bought shares, NODELMAN OLEG acquired of 5,143,000 shares on Feb 19 at a per-share price of $1.26. This resulted in the Director holding 12,504,675 shares of NUVB after the transaction. In another insider transaction, FALBERG KATHRYN E bought 43,000 shares at $1.95 per share on Dec 05. Company shares held by the Director now total 250,000.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for NUVB in the last 3 months, the mean price target is $4.08 with high estimates of $5.00 and low estimates of $1.80. In terms of 52-week highs and lows, NUVB has a high of $2.55 and a low of $0.95.
As of this writing, NUVB has an earnings estimate of -$0.11 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.1 per share and a lower estimate of -$0.13.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. NUVB’s latest balance sheet shows that the firm has $765.39M in Cash & Short Term Investments as of fiscal 2021. There were $3.06M in debt and $16.93M in liabilities at the time. Its Book Value Per Share was $2.84, while its Total Shareholder’s Equity was $746.00M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NUVB is Buy with a score of 4.17.
